
zzso is increasingly being used to treat zzso region tumors, either as an additional therapy after conventional treatments or as a primary zzso We report our experience with zzso zzso zzso zzso for the treatment of zzso and related zzso zzso patients underwent zzso for zzso and related tumors zzso zzso zzso between February 1992 and September zzso The diagnosis was germ cell tumors zzso in 38 patients zzso zzso zzso zzso tumors zzso in 9 (19 zzso and unknown in 2 (2 zzso The mean treatment volume was zzso zzso zzso zzso zzso in zzso cases and zzso zzso zzso zzso zzso in zzso zzso zzso doses around 50% zzso line ranged from zzso to zzso zzso One patient (one zzso with zzso was lost to zzso Median clinical and imaging follow-up in the remaining 48 cases was zzso months zzso zzso zzso Survival rates at 5 years and 10 years after zzso in zzso cases zzso zzso zzso were both zzso They were 100 and zzso respectively, in zzso cases zzso zzso zzso We evaluated the treatment results with categorization of zzso cases into 2 groups, zzso zzso zzso 1), and zzso with zzso giant cell and zzso zzso zzso zzso zzso cases were also divided into 2 groups, zzso zzso zzso 3) and zzso and mixed zzso zzso zzso Local tumor control zzso rates at 3 and 5 years were zzso in group 1 zzso zzso zzso 72 and zzso in group 2 zzso zzso zzso and zzso in group 3 zzso zzso zzso zzso rate at 2 years was zzso in group 4 zzso zzso zzso In group 1 zzso zzso zzso zzso survival zzso rates at 3 and 5 years were 79 and zzso They were 43 and 37% in group 2 zzso zzso zzso and zzso in group 3 zzso zzso zzso zzso rate at 2 years was zzso in group 4 zzso zzso zzso zzso and zzso showed higher zzso and zzso rates after zzso though zzso was liable to zzso Intermediate prognosis was obtained in zzso with zzso giant cell and zzso zzso zzso is expected to be an effective and safe zzso treatment approach to zzso and related zzso 

